Purchase Order N3239825P0044
- Not listed
- This federal contract award is to Caredx Lab Solutions Inc., a for-profit organization and manufacturer of goods that specializes in genomics-based solutions for transplant patients. The contract, valued at $90,932.49, is a firm fixed-price purchase order for laboratory supplies from the Defense Health Agency, a defense agency. The award is not associated with a set-aside designation, indicating Caredx Lab Solutions Inc. competed for the contract based on its technical capabilities and expertise...
- This federal contract award to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., was made by the National Institutes of Health (NIH) Clinical Center. The $4,936.40 firm fixed-price purchase order was awarded on March 23, 2018, with a completion date of April 22, 2018. The contract does not have a set-aside designation. Caredx Lab Solutions is a provider of genomics-based solutions for transplant patients, specializing in molecular testing services, diagnostic kits, and related products....
- This contract award to Caredx Lab Solutions Inc. is a firm-fixed-price purchase order from the Defense Health Agency, valued at $30,000.00, to provide lab supplies. The award does not have a set-aside designation. Caredx Lab Solutions Inc. is a subsidiary of Caredx, Inc., a provider of genomics-based solutions for transplant patients. This contract is part of a larger Indefinite Delivery Contract the company holds with the Department of Veterans Affairs (VA) Veterans Health Administration,...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 17 to Caredx Lab Solutions Inc., a for-profit manufacturer of genomics-based solutions for transplant patients. The $59,931.70 contract provides CAREDX ALLOMAP molecular testing services to support post-transplant surveillance and patient management for heart transplant recipients within the VA network. The contract is an indefinite delivery vehicle with a...
- This federal contract award to Caredx, Inc., a for-profit medical testing company, is for the provision of specialized genetic testing services to support organ transplant programs for the U.S. Department of Veterans Affairs (VA). The contract, valued at $529,760.00, is a delivery order awarded under a larger Indefinite Delivery Vehicle (IDV) contract with a $1,963,141.20 ceiling for genetic blood testing services. Caredx will supply the VA with its AlloSure kidney and heart tests, AlloMap heart...
- The federal contract award is for laboratory services provided by Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract, valued at $241,463.75, was awarded by the U.S. Department of Veterans Affairs (VA) to Caredx for the delivery of advanced genetic and molecular testing solutions focused on organ transplant diagnostics. The contract, which has a completion date of January 14, 2026, is a Firm Fixed Price Delivery Order, with no set-aside...
- This is a $193,171.00 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract is for laboratory reference testing services, specifically Caredx's specialized diagnostic solutions for organ transplant patients, including its AlloMap and AlloSure genetic and molecular testing products. The contract has an ultimate completion date of January 14,...
- This federal contract award, valued at $244,905.33, was issued by the Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit medical technology company specializing in diagnostic solutions for organ transplant patients. The contract is for the delivery of testing kits to support post-transplant patient care. Caredx is an experienced federal contractor, having secured numerous awards from the VA and other agencies like the National Institutes of Health (NIH) and Centers for Disease...
- This federal contract award is for "TRANSPLANT LABORATORY TESTING" services provided by Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services to support organ transplant programs. The contract, valued at $205,530.69, was awarded by the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9 (VISN 9). The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract valued at...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $140,040.00 firm fixed price purchase order to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc. The contract is for the delivery of 7 ASTX17.1(96)-B-RUO KITS, with a completion date of August 30, 2023. Caredx, Inc. is a for-profit company that provides kidney care solutions, including specialized testing kits and services related to organ transplant patients. The company has previously...
Caredx Lab Solutions Inc. has been awarded a $200,000 firm fixed-price purchase order by the Naval Medical Research Command's Bone Marrow Program, under the Bureau of Medicine and Surgery within the Department of Defense. The contract, effective July 28, 2025, with an ultimate completion date of July 27, 2026, will be performed at the company's Rockville, Maryland facility. No set-aside designation was applied to this award, indicating the contract was competed on the basis of technical capability and pricing. Caredx Lab Solutions specializes in genomics-based diagnostic solutions for transplant patients, with particular expertise in molecular testing and next-generation sequencing technologies. The company's federal contract portfolio demonstrates consistent engagement with the Department of Defense, Department of Veterans Affairs, National Institutes of Health, and Centers for Disease Control and Prevention on specialized medical testing initiatives. This award supports the Naval Medical Research Command's bone marrow program objectives through the delivery of advanced diagnostic services and reagent kits aligned with the company's core competencies in transplant-related molecular diagnostics and immunosuppression protocol assessments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $200.0k | 7/28/25 |